{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:29:43Z","timestamp":1793478583376,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156710","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:51:40Z","timestamp":1792079500000},"page":"156710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quercetin in oral squamous cell carcinoma: Integrating immunometabolic reprogramming, cancer stem cell plasticity, and precision therapeutic strategies"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8641-2764","authenticated-orcid":false,"given":"Rohit","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatrudhan","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156710_bib1","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/curroncol30040283","article-title":"Oral squamous cell carcinoma and concomitant primary tumors, what do we know? A review of the literature","volume":"30","author":"Badwelan","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_389810","article-title":"Current treatment strategies and risk stratification for oral carcinoma","author":"Mohamad","year":"2023","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.prp.2026.156710_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/biomedicines11041112","article-title":"Oral cavity squamous cell carcinoma: an update of the pharmacological treatment","volume":"11","author":"Imbesi Bellantoni","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2026.156710_bib4","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.38301","article-title":"The incidence and severity of patient-reported side effects of chemotherapy in routine clinical care: a prospective observational study","author":"Katta","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2026.156710_bib5","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.3390\/cancers14246203","article-title":"Natural products\/bioactive compounds as a source of anticancer drugs","volume":"14","author":"Asma","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib6","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms20133177","article-title":"The anti-cancer effect of quercetin: molecular implications in cancer metabolism","volume":"20","author":"Reyes-Farias","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156710_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12672-024-01239-y","article-title":"Nanoquercetin based nanoformulations for triple negative breast cancer therapy and its role in overcoming drug resistance","volume":"15","author":"Samantaray","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib8","article-title":"Quercetin as a therapeutic agent for oral cancer: current evidence and future directions","author":"Sun","year":"2025","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12935-025-03694-1","article-title":"Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis","volume":"25","author":"Saadh","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.prp.2026.156710_bib10","first-page":"842","article-title":"Molecular and genetic pathogenesis of oral cancer: a basis for customized diagnosis and treatment","volume":"14","author":"Barroso","year":"2025","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib11","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/cancers13235905","article-title":"The epithelial\u2013mesenchymal transition influences the resistance of oral squamous cell carcinoma to monoclonal antibodies via its effect on energy homeostasis and the tumor microenvironment","volume":"13","author":"Bai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib12","article-title":"Unravelling the role of EMT in OSCC: a quick peek into HPV-mediated pathogenesis","volume":"5","author":"Saraf","year":"2023","journal-title":"Oral. Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156710_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/jop.70126","article-title":"Epithelial-mesenchymal transition, immune response, and extracellular matrix remodelling in oral cancer","author":"Lonni","year":"2026","journal-title":"J. Oral. Pathol. & Med."},{"key":"10.1016\/j.prp.2026.156710_bib14","doi-asserted-by":"crossref","DOI":"10.4103\/jomfp.JOMFP_334_19","article-title":"Epithelial\u2013mesenchymal transition in oral squamous cell carcinoma: an insight into molecular mechanisms and clinical implications","volume":"24","author":"Jayanthi","year":"2020","journal-title":"J. Oral. Maxillofac. Pathol."},{"key":"10.1016\/j.prp.2026.156710_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1113137","article-title":"Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma","volume":"14","author":"Ai","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2026.156710_bib16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/cancers16061185","article-title":"EMT dynamics in lymph node metastasis of oral squamous cell carcinoma","volume":"16","author":"Ghantous","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12967-025-06422-5","article-title":"Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges","volume":"23","author":"Xie","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2026.156710_bib18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/cancers17111761","article-title":"The interplay of SMAD4 and EMT in oral squamous cell carcinoma","volume":"17","author":"Mozalbat","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/ph16111631","article-title":"Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications\u2014a review","volume":"16","author":"Mirza","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156710_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/molecules29051000","article-title":"Quercetin, a flavonoid with great pharmacological capacity","volume":"29","author":"Carrillo-Martinez","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156710_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","article-title":"Recent advances on the improvement of quercetin bioavailability","volume":"119","author":"Kandemir","year":"2022","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.prp.2026.156710_bib22","article-title":"Recent advances and application challenges of quercetin-loaded delivery systems: from material selection to bioavailability","author":"Bai","year":"2025","journal-title":"J. Future Foods"},{"key":"10.1016\/j.prp.2026.156710_bib23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/10717544.2021.1927244","article-title":"Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions","volume":"28","author":"Li","year":"2021","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.prp.2026.156710_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2025.143630","article-title":"Improving quercetin bioavailability: a systematic review and meta-analysis of human intervention studies","volume":"477","author":"Liu","year":"2025","journal-title":"Food Chem."},{"key":"10.1016\/j.prp.2026.156710_bib25","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/nano11102658","article-title":"Nanotechnology innovations to enhance the therapeutic efficacy of quercetin","volume":"11","author":"Pinheiro","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.prp.2026.156710_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.31557\/APJCP.2023.24.1.283","article-title":"Quercetin induces cell cycle arrest and apoptosis in yd10b and yd38 oral squamous cell carcinoma cells","volume":"24","author":"Son","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2026.156710_bib27","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.3390\/molecules27196545","article-title":"Quercetin: its antioxidant mechanism, antibacterial properties and potential application in prevention and control of toxipathy","volume":"27","author":"Qi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156710_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1800322","article-title":"Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers","volume":"17","author":"Song","year":"2026","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2026.156710_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/17568919.2024.2347067","article-title":"Exploring the current advancements of quercetin nanoformulations alleviating respiratory diseases","volume":"16","author":"Yeung","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.prp.2026.156710_bib30","article-title":"Therapeutic potential of quercetin in oral squamous cell carcinoma: mechanisms, epigenetic modulation, and anti-metastatic effects","volume":"9","author":"Rajaram","year":"2025","journal-title":"J. Glob. Oral. Health"},{"key":"10.1016\/j.prp.2026.156710_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/pharmaceutics15020712","article-title":"Apoptotic mechanisms of quercetin in liver cancer: recent trends and advancements","volume":"15","author":"Sethi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156710_bib32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/1759-7714.13925","article-title":"Quercetin induces pro-apoptotic autophagy via <scp>SIRT1<\/scp> \/ <scp>AMPK<\/scp> signaling pathway in human lung cancer cell lines <scp>A549<\/scp> and <scp>H1299<\/scp> in vitro","volume":"12","author":"Guo","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.prp.2026.156710_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/metabo13020229","article-title":"Quercetin induces apoptosis in HepG2 cells via directly interacting with YY1 to Disrupt YY1-p53 interaction","volume":"13","author":"Guan","year":"2023","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.prp.2026.156710_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/0960327121991912","article-title":"Quercetin suppresses cell survival and invasion in oral squamous cell carcinoma via the miR-1254\/CD36 cascade in vitro","volume":"40","author":"Chen","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.prp.2026.156710_bib35","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.prp.2026.156710_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-026-02583-x","article-title":"Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications","volume":"11","author":"Akter","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156710_bib37","doi-asserted-by":"crossref","first-page":"11746","DOI":"10.3390\/ijms231911746","article-title":"A comprehensive analysis and anti-cancer activities of quercetin in ros-mediated cancer and cancer stem cells","volume":"23","author":"Biswas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156710_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2026.156710_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125874","article-title":"Immunometabolic reprogramming, another cancer hallmark","volume":"14","author":"Kumar","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156710_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104844","article-title":"Novel insight into the Warburg effect: sweet temptation","volume":"214","author":"Zhang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2026.156710_bib41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10735-026-10863-7","article-title":"Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects","volume":"57","author":"Kumari","year":"2026","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.prp.2026.156710_bib42","article-title":"Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment: mechanisms and therapeutics","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2026.156710_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00044-025-03514-1","article-title":"Direct targeting of GLUT1 in cancer: a decade of inhibitor discovery and medicinal chemistry insights","volume":"35","author":"Meng","year":"2026","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.prp.2026.156710_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/odi.70318","article-title":"Molecular insights into phytochemicals as modulators in oral squamous cell carcinoma","author":"Nakhaei","year":"2026","journal-title":"Oral. Dis."},{"issue":"12","key":"10.1016\/j.prp.2026.156710_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.71241","article-title":"Exploring molecular targets of quercetin for the treatment of nicotine-related oral carcinoma: a network pharmacology analysis and in vitro study","volume":"13","author":"Guo","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.prp.2026.156710_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13046-024-03141-5","article-title":"Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma","volume":"43","author":"Gupta","year":"2024","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156710_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11033-026-12041-0","article-title":"Quercetin as a multi-targeted therapeutic candidate in oral cancers: molecular mechanisms and preclinical evidence","volume":"53","author":"Abuhassan","year":"2026","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156710_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/15376516.2022.2103480","article-title":"Quercetin acts via the G3BP1\/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma","volume":"33","author":"Hu","year":"2023","journal-title":"Toxicol. Mech. Methods"},{"issue":"6","key":"10.1016\/j.prp.2026.156710_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/15376516.2024.2325989","article-title":"Quercetin induces ferroptosis by inactivating mTOR\/S6KP70 pathway in oral squamous cell carcinoma","volume":"34","author":"Zhu","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.prp.2026.156710_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125224","article-title":"Light-activated photosensitizer\/quercetin co-loaded extracellular vesicles for precise oral squamous cell carcinoma therapy","volume":"671","author":"Liu","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2026.156710_bib51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/antiox14050508","article-title":"Oxidative stress and dietary antioxidants in head and neck cancer","volume":"14","author":"You","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.prp.2026.156710_bib52","article-title":"Natural products as adjuvants to enhance the efficacy of immune checkpoint inhibitors in overcoming drug resistance and improving antitumor responses","author":"Zhou","year":"2025","journal-title":"Food Sci. Human. Wellness"},{"key":"10.1016\/j.prp.2026.156710_bib53","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1038\/s41591-025-03873-7","article-title":"Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results","volume":"31","author":"Liu","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2026.156710_bib54","article-title":"Ferroptosis contributes to quercetin-induced anti-cancer activity through blockade of LGR4\/NF-\u03baB\/GPX4 axis in oral squamous cell carcinoma","volume":"16","author":"Wang","year":"2026","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1790855","article-title":"Cisplatin resistance in oral squamous cell carcinoma: mechanisms, reversal strategies, and emerging technologies","volume":"17","author":"Shi","year":"2026","journal-title":"Front. Physiol."},{"key":"10.1016\/j.prp.2026.156710_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.71378","article-title":"Changes in cancer stem cell signalling pathways with plant metabolites to discover chemotherapy","volume":"23","author":"Rizvi","year":"2026","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.prp.2026.156710_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1619597","article-title":"Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities","volume":"13","author":"Yin","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.prp.2026.156710_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-025-04859-5","article-title":"The potential and promise of natural antioxidants as epigenetic modulators in oral squamous cell carcinoma","volume":"96","author":"Jha","year":"2026","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.prp.2026.156710_bib59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/ph19030471","article-title":"From environmental risk to cancer stemness: epigenetic regulation in oral squamous cell carcinoma","volume":"19","author":"Jaksic Karisik","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156710_bib60","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s12672-025-03190-y","article-title":"Therapeutic potential of natural compounds in targeting cancer stem cells: a promising approach for cancer treatment","volume":"16","author":"Debnath","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11095-025-03836-0","article-title":"Phytochemicals and their nanoformulations for overcoming drug resistance in head and neck squamous cell carcinoma","volume":"42","author":"Pingping","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.prp.2026.156710_bib62","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S570558","article-title":"Quercetin-based advanced delivery systems - from multimodal nano-theranostics to microneedles: a recent update on their preclinical studies","volume":"21","author":"Beena","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2026.156710_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/biomedicines14010215","article-title":"Targeting cancer stem cells with phytochemicals: molecular mechanisms and therapeutic potential","volume":"14","author":"Sah","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2026.156710_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41368-025-00417-0","article-title":"Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation","volume":"18","author":"Wang","year":"2026","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.prp.2026.156710_bib65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156710_bib66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13167-025-00407-6","article-title":"Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients","volume":"16","author":"Kubatka","year":"2025","journal-title":"EPMA J."},{"issue":"1","key":"10.1016\/j.prp.2026.156710_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cells12010179","article-title":"Oral squamous cell carcinoma cells with acquired resistance to erlotinib are sensitive to anti-cancer effect of quercetin via pyruvate kinase M2 (PKM2)","volume":"12","author":"Chan","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156710_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)","volume":"63","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib69","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156710_bib70","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/polym17111453","article-title":"Chitosan nanoparticle-based drug delivery systems: advances, challenges, and future perspectives","volume":"17","author":"Stefanache","year":"2025","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.998222","article-title":"Artificial intelligence assists precision medicine in cancer treatment","volume":"12","author":"Liao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib72","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.2147\/IJN.S377816","article-title":"Personalized targeted therapeutic strategies against oral squamous cell carcinoma. an evidence-based review of literature","volume":"17","author":"Cao","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2026.156710_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12672-025-04222-3","article-title":"Research progress on carcinogenic factors and personalized treatment of oral cancer","volume":"17","author":"Xu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/lifemedi\/lnag011","article-title":"The multistep progression of areca nut-induced oral cancer: a mechanistic roadmap from pathogenesis to precision therapy","volume":"5","author":"Yu","year":"2026","journal-title":"Life Med."},{"key":"10.1016\/j.prp.2026.156710_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.65795\/xmgwda06","article-title":"Integrative role of natural bio-actives in oral cancer therapy: mechanisms of protection and efficacy","volume":"40","author":"Mary Martin","year":"2026","journal-title":"Trends Biomater. Artif. Organs"},{"key":"10.1016\/j.prp.2026.156710_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10565-025-10048-0","article-title":"Oral squamous cell carcinoma: insights into cellular heterogeneity, drug resistance, and evolutionary trajectories","volume":"41","author":"Zhou","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.prp.2026.156710_bib77","doi-asserted-by":"crossref","DOI":"10.2174\/0118715206432579251210114013","article-title":"Recent advances in natural phytocompounds for the chemotherapeutic management of head and neck squamous cell carcinoma from 2018 to 2024","volume":"26","author":"Nooreen","year":"2026","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.prp.2026.156710_bib78","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00432-022-04028-8","article-title":"Current trends of targeted therapy for oral squamous cell carcinoma","volume":"148","author":"Li","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib79","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s13402-025-01068-3","article-title":"Trends in immunotherapy for oral squamous cell carcinoma","volume":"48","author":"Xue","year":"2025","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.prp.2026.156710_bib80","doi-asserted-by":"crossref","first-page":"10699","DOI":"10.2147\/IJN.S481901","article-title":"Photodynamic therapy for oral squamous cell carcinoma: current status, challenges, and prospects","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.prp.2026.156710_bib81","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.chest.2019.02.318","article-title":"A diagnostic conundrum: progressive tubular lung mass in asymptomatic young woman","volume":"155","author":"Shostak","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.prp.2026.156710_bib82","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3390\/cancers18132047","article-title":"Breaking the efflux barrier: P-glycoprotein and emerging strategies to overcome multidrug resistance in cancer","volume":"18","author":"Nicolae","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156710_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.71107","article-title":"Emerging therapeutic strategies in oral cancer: epigenetic, mitochondrial and immunotherapy approaches","volume":"30","author":"Shanmugam","year":"2026","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2026.156710_bib84","article-title":"Oral cancer: recent breakthroughs in pathology and therapeutic approaches","volume":"12","author":"Ramachandran","year":"2024","journal-title":"Oral. Oncol. Rep."},{"key":"10.1016\/j.prp.2026.156710_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2026.1875636","article-title":"Revisiting the grand challenges in oral cancers: advances in biomarkers and treatment strategies","volume":"7","author":"Coletta","year":"2026","journal-title":"Front. Oral. Health"},{"issue":"18","key":"10.1016\/j.prp.2026.156710_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37518","article-title":"Quercetin represses cholesterol metabolism and mitigates resistance to cisplatin in oral squamous cell carcinoma by regulating AGR2\/AKT\/SREBP2 axis","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.prp.2026.156710_bib87","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/01635581.2021.1952440","article-title":"Efficacy of nutrients in reducing the symptoms of radiation induced oral mucositis in a hamster model","volume":"74","author":"Dvoretskiy","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.prp.2026.156710_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning cold tumors into hot tumors to ignite immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156710_bib89","article-title":"Advances in nanoparticles in targeted drug delivery\u2013A review","volume":"19","author":"Islam","year":"2025","journal-title":"Results Surf. Interfaces"},{"key":"10.1016\/j.prp.2026.156710_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156710_bib91","doi-asserted-by":"crossref","DOI":"10.2174\/0113816128454401260616195045","article-title":"Precision nanotechnology in oral oncology: from biomarker-guided targeting to AI-driven theranostics","author":"Das","year":"2026","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2026.156710_bib92","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","article-title":"Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents","volume":"22","author":"Doostmohammadi","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.prp.2026.156710_bib93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/molecules25030757","article-title":"Quercetin inhibits cell survival and metastatic ability via the EMT-mediated pathway in oral squamous cell carcinoma","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules"},{"issue":"Pt 2","key":"10.1016\/j.prp.2026.156710_bib94","article-title":"Dual inhibition strategy against EGFR utilizing quercetin and 5-fluorouracil: a computational analysis for oral cancer treatment","volume":"124","author":"Haroon","year":"2026","journal-title":"Comput. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156710_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3892\/ol.2022.13198","article-title":"Quercetin induces tongue squamous cell carcinoma cell apoptosis via the JNK activation-regulated ERK\/GSK-3\u03b1\/\u03b2-mediated mitochondria-dependent apoptotic signaling pathway","volume":"23","author":"Huang","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2026.156710_bib96","article-title":"Patient-derived organoids for personalized drug response profiling and multi-omics integration in oral squamous cell carcinoma","volume":"29","author":"Li","year":"2026","journal-title":"IScience"},{"key":"10.1016\/j.prp.2026.156710_bib97","article-title":"A human patient-derived organoid biobank to model tumor heterogeneity and therapeutic vulnerability for oral squamous cell carcinoma","volume":"7","author":"Wang","year":"2026","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.prp.2026.156710_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2026.106520","article-title":"Comparative analysis of patient-derived organoids among oral squamous cell carcinoma and mucosa identifies the distinct features","volume":"184","author":"Gan","year":"2026","journal-title":"Arch. Oral. Biol."},{"issue":"3","key":"10.1016\/j.prp.2026.156710_bib99","first-page":"ZC46","article-title":"A randomized placebo- controlled double blind clinical trial of quercetin in the prevention and treatment of chemotherapy-induced oral mucositis","volume":"11","author":"Kooshyar","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.prp.2026.156710_bib100","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.7150\/jca.31045","article-title":"Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-\u03baB pathway","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156710_bib101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0044-1789016","article-title":"Anticancer potential of quercetin on oral squamous cell carcinoma: a scoping review and molecular docking","volume":"19","author":"Afriza","year":"2025","journal-title":"Eur. J. Dent."},{"issue":"22","key":"10.1016\/j.prp.2026.156710_bib102","doi-asserted-by":"crossref","first-page":"12091","DOI":"10.3390\/ijms252212091","article-title":"A systematic review: quercetin-secondary metabolite of the flavonol class, with multiple health benefits and low bioavailability","volume":"25","author":"Fren\u021b","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156710_bib103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12906-025-04782-5","article-title":"Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2\/M-phase cell cycle arrest in KON oral cancer cells","volume":"25","author":"Tubtimsri","year":"2025","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.prp.2026.156710_bib104","article-title":"Recent advances in cancer nanomedicine: from smart targeting to personalized therapeutics - pioneering a new era in precision oncology","volume":"36","author":"Younas","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.prp.2026.156710_bib105","article-title":"Cancer immunotherapy in combination with radiotherapy and\/or chemotherapy: mechanisms and clinical therapy","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.prp.2026.156710_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2026.100299","article-title":"Emerging frontiers of responsive nanomaterials in drug delivery systems: from design to clinical translation","volume":"29","author":"Bhairam","year":"2026","journal-title":"OpenNano"},{"issue":"7","key":"10.1016\/j.prp.2026.156710_bib107","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/ijms27072956","article-title":"Molecular mechanisms in oral squamous cell carcinoma: integrative roles of cancer-associated fibroblasts, immune microenvironment, and precision therapeutic opportunities","volume":"27","author":"Tsai","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156710_bib108","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41419-024-07077-8","article-title":"Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research","volume":"15","author":"Son","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.prp.2026.156710_bib109","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.3390\/molecules30224441","article-title":"Quercetin and its metabolites: mechanistic insights as the basis of their therapeutic potential in NAFLD and HCC","volume":"30","author":"Li","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2026.156710_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2026.101701","article-title":"Pharmacometrics-driven dose individualization of modified-release formulations: integration of PopPK, PBPK, and PK\/PD modeling","author":"Abdul Rasool","year":"2026","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.prp.2026.156710_bib111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13073-022-01102-1","article-title":"Clinical trial design in the era of precision medicine","volume":"14","author":"Fountzilas","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.prp.2026.156710_bib112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/pharmaceutics18010062","article-title":"Quality by design for the nanoformulation of cosmeceuticals","volume":"18","author":"Leyva-G\u00f3mez","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156710_bib113","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156710_bib114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drudis.2019.11.001","article-title":"Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems","volume":"25","author":"Khursheed","year":"2020","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.prp.2026.156710_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251323753","article-title":"Activation of SIRT3\/AMPK\/mTOR-mediated autophagy promotes quercetin-induced ferroptosis in oral squamous cell carcinoma","volume":"44","author":"Wang","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.prp.2026.156710_bib116","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1002\/cam4.1411","article-title":"Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health","volume":"9","author":"Rather","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2026.156710_bib117","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.31557\/APJCP.2022.23.12.4145","article-title":"Quercetin effects on cell cycle arrest and apoptosis and doxorubicin activity in T47D cancer stem cells","volume":"23","author":"Azizi","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:41:57Z","timestamp":1793475717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S0344033826003638"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156710","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercetin in oral squamous cell carcinoma: Integrating immunometabolic reprogramming, cancer stem cell plasticity, and precision therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156710"}}